What is Ginkgo Bioworks's cash ratio?

Ginkgo Bioworks (DNA) reported cash ratio of 2.4× in Q1 2026.

How has Ginkgo Bioworks's cash ratio changed year-over-year?

Ginkgo Bioworks's cash ratio decreased by 22.9% year-over-year, from 3.1× to 2.4×.

What is the long-term trend for Ginkgo Bioworks's cash ratio?

Over 5 years (2020 to 2025), Ginkgo Bioworks's cash ratio has grown at a -15.9% compound annual growth rate (CAGR), from 5.3× to 2.2×.

What does cash ratio mean?

Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.

Ginkgo Bioworks DNA Cash ratio

Cash ratio at other companies

Thermo Fisher ScientificTMO

0.2×-0.1×

Charles River LaboratoriesCRL

0.2×0.0×

AbCellera Biologics Inc.ABCL

2.2×-0.3×

TEC

Bio-TechneTECH

1.4×+0.5×

AzentaAZTA

0.5×—

RegenxbioRGNX

0.2×-1.0×

Other financials

Income statement

See full

Revenue$19.5M-49.1%

Gross profit$16.4M-52.0%

Operating income-$71.4M+11.9%

Net income-$82.6M+9.2%

EPS (diluted)-$1.42+27.6%

Balance sheet

See full

Cash & equivalents$188.7M-46.9%

Total debt$410.7M-5.5%

Total equity$443.2M-31.6%

Total assets$1.0B-20.1%

Cash flow

See full

Operating cash flow-$46.7M+9.4%

CapEx$1.9M-74.6%

Free cash flow-$48.6M+17.8%

Valuation

See full

Market cap$625.16M+24.6%

Enterprise value$847.19M+45.9%

P/S4.4×+2.2×

Profitability

See full

Operating margin-210.7%+7.6pp

Net margin-215.4%+8.3pp

FCF margin-119%-21.2pp

Returns & leverage

See full

Return on equity-55.8%-1.8pp

Debt / equity0.9×+0.3×

Current ratio5.2×+0.3×

Where this comes from

Calculated from Ginkgo Bioworks’s reported figures.

cash and equivalents/total current liabilities=2.4×

Based on the most recent quarter.

The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ginkgo Bioworks's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ginkgo Bioworks's cash ratio?: Ginkgo Bioworks (DNA) reported cash ratio of 2.4× in Q1 2026.
How has Ginkgo Bioworks's cash ratio changed year-over-year?: Ginkgo Bioworks's cash ratio decreased by 22.9% year-over-year, from 3.1× to 2.4×.
What is the long-term trend for Ginkgo Bioworks's cash ratio?: Over 5 years (2020 to 2025), Ginkgo Bioworks's cash ratio has grown at a -15.9% compound annual growth rate (CAGR), from 5.3× to 2.2×.
What does cash ratio mean?: Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.